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Abstract. A flow-injection spectrophotometric method is developed for determination of N-acetyl-L-
cysteine (NAC) in pharmaceutical formulations. The method is based on coupled redox-complexation 
reaction, the first step of which is the reduction of FeIII by NAC; the second one includes the complexation 
of FeII, resulting from the preceding redox reaction, with 2,4,6-tripyridyl-s-triazine (TPTZ). The stable 
Fe(TPTZ)22+ complex exhibits an absorption maximum at λ = 593 nm. Under experimental conditions,  
optimized by univariate method, a linear calibration curve is established in NAC concentration range from 
6.0 × 10−6 mol L–1 to 2.0 × 10–4 mol L–1 with NAC detection limit of 2.0 × 10–6 mol L–1. The analytical fre-
quency was 60 h–1. Usual excipients used as additives in pharmaceuticals do not interfere with the analysis 
of NAC. The proposed method is simple, rapid, sensitive, accurate and precise (repeatability RSD 0.29 %, 
n = 10), and can be applied for determination of NAC in pharmaceutical formulations up to nano-  
mole quantity. (doi: 10.5562/cca1753) 
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INTRODUCTION 
N-Acetyl-L-cysteine (NAC) is a synthetic aminothiol 
antioxidant with a mucolytic effect, shown to be effec-
tive in the management of paracetamol (acetaminophen) 
poisoning. In addition, it is being studied and utilized 
for curing HIV infection, cancer and heart disease.1 
Several analytical methods have been reported for 
NAC determination in pharmaceutical formulations, 
including spectrophotometry,2–7 fluorimetry,8,9 chroma-
tography10,11 and electrochemistry.12,13 Some of the 
methods described above are not simple for direct appli-
cation in a large-scale routine analysis and require  
expensive or sophisticated instruments. 
In recent years, more strict regulation related  
to the quality control in pharmaceuticals led to increas-
ing demands on automation of the analytical assays 
carried out in appropriate control laboratories. The flow-
injection analysis (FIA) became a versatile instrumental 
tool that contributed substantially to the development  
of automation in pharmaceutical analysis due to its 
simplicity, low cost and relatively short analysis time.14 
There are several published flow-injection me-
thods for the determination of NAC with potentio-
metric15,16 and spectrophotometric detector.17–23 De-
scribed flow-injection spectrometric methods have ade-
quate sample analysis frequency but, on the other hand, 
narrow analytical range and lack of sensitivity. Fatibel-
lo-Filho and co-workers use in their studies laboratory-
constructed (custom-made) manual injector-commutator 
as part of flow-injection system.19–21 This manual injec-
tor-commutator is commercially not available and hence 
not obtainable for use in other labora-tories. 
In this work 2,4,6-tripyridyl-s-triazine (TPTZ) was 
proposed as a chromogenic reagent for the determina-
tion of NAC in aqueous laboratory samples, instead of 
frequently employed 1,10-phenantroline.5,21 The use of 
TPTZ as chromogenic reagent has improved selectivity, 
linearity and sensitivity of measurements. Reaction 
mechanism of the method is based on the coupled re-
dox-complexation reaction between NAC, FeIII and 
TPTZ. The coloured complex of FeII with TPTZ was 
monitored at λ = 593 nm. A simple flow-injection system 
for NAC determination was developed. The proposed 
procedure is simple, inexpensive, does not involve any 
pre-treatment procedure and has a high sample analysis 
frequency. The method was successfully applied for 
determination of NAC in pharmaceutical formulations.  
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EXPERIMENTAL 
Instrumentation 
The flow-injection manifold for spectrophotometric 
determination of NAC is shown in Figure 1. The set-up 
consisted of a Shimadzu UV-1601 (Shimadzu, Kyoto, 
Japan) UV/Vis spectrophotometer equipped with a flow 
cell of 160 µL internal volume and 10 mm optical path. 
The instrument was set at λ = 593 nm for all absorbance 
measurements and the output signals were recorded by 
coupling the spectrophotometer to a computer equipped 
with Hyper UV software provided by Shimadzu. An 
Ismatec IPC eight-channel peristaltic pump (Ismatec, 
Zurich, Switzerland), equipped with flexible Tygon 
tubes (grey/grey 1.30 mm I.D.), was used to deliver 
sample, sample carrier and reagent solution. A Rheo-
dyne low pressure Teflon six port rotary valve, Model 
5020 (Anachem, Luton, UK) was employed to inject 
samples and standard solutions into the system. The 
manifold was built up with polytetrafluoroethylene 
(PTFE) tubes with 0.8 mm bore and with Chemifold 
Type II (Tecator, USA). Adjustments and measurements 
of pH were carried out with a Mettler Toledo Seven-
Multi potentiometer (Mettler Toledo, Schwerzenbach, 
Switzerland) equipped with combined glass electrode 
Mettler Toledo InLab®413. 
A thermostated constant temperature water bath 
accurate to ± 0.5 °C was used. 
 
Materials 
All chemicals were of analytical-reagent grade, and 
solutions were prepared with deionised water. All stock 
solutions were stored at 4 °C in dark bottles. 
A stock solution of NAC (1.0 × 10–2 mol L–1) was pre-
pared by dissolving 163.2 mg of NAC in 100.0 mL of 
deionised water. Working solutions of lower concentra-
tion were prepared daily by appropriate dilution of the 
stock solution with deionised water. 
A stock solution of FeIII (1.0 × 10–2 mol L–1) was 
prepared by dissolving 270.3 mg of FeCl3 × 6 H2O in a 
portion of deionised water, to which 0.5 mL of concen-
trated hydrochloric acid was added, before making up to 
a volume of 100.0 mL.  
A stock solution of TPTZ, 1.0 × 10–2 mol L–1, was 
prepared by dissolving 312.3 mg in 2.0 mL of HCl  
(c(HCl) = 6.0 mol L–1), and diluted to 100.0 mL with 
deionised water.  
Acetate buffer solutions (c = 0.5 mol L–1) covered 
the pH range 3.2 to 4.0. For the pH range 1.0 to 2.0 
solutions of 0.1 mol L–1 HCl (pH = 1.0) and 0.01 mol L–1 
HCl (pH = 2.0) were used. 
 
Sample Preparation 
The commercial pharmaceutical formulations analysed 
by developed flow-injection spectrophotometric method 
were granules, Fluimukan 100 mg, syrup, Fluimukan 
Akut Junior and dispersible tablets, Fluimukan Akut 
600 mg, all produced by Lek, Ljubljana, Slovenia. The 
contents of five granules units were powdered in a mor-
tar and an accurately weighed portion of the homoge-
nized powder containing about 100 mg of NAC was 
transferred to a 250 mL volumetric flask and diluted to a 
nominal volume with deionised water. The 5 mL por-
tion of syrup, containing about 100 mg of NAC, was 
transferred to a 250 mL volumetric flask and diluted to a 
nominal volume with deionised water. One dispersible 
tablet was dissolved in 1000 mL of deionised water. 
Additional dilutions (10/1000) were necessary to obtain 
a final concentration of a sample solution that was ana-
lysed using proposed flow injection procedure. 
 
Flow-injection Procedure 
In the developed flow system, depicted in Figure 1, the 
loop (500 µL) of the rotary valve was filled with the 
sample (or standard solution) while the ultra pure water 
carrier stream (CS) was mixed with the reagent solution 
(RS: 1.0 × 10–3 mol L–1 FeIII and 1.0 × 10–3 mol L–1 TPTZ 
in acetate buffer solution, pH = 3.6), yielding the final 
stream that allowed the establishment of the baseline. 
By valve switching, the sample or standard solutions 
were injected (in triplicates) in the carrier stream, and 
thus formed sample zone flowed to the confluence point 
(CP) where it was mixed with reagent stream. The se-
lected analytical frequency was 60 h–1. For confluence 
point Chemifold Type II (Tecator, USA) has been used. 
The final stream subsequently flowed to the reactor 
(RC) in coiled form (length: 300 cm, i.d. 0.8 mm, which 
corresponds to a volume of 1.50 mL) where the coup- 
led reaction took place. After colour development, the  
 
Figure 1. Flow-injection manifold configuration. S: sample or 
standard solution (NAC); CS: carrier stream (ultra pure wa-
ter); RS: reagent stream (1.0 × 10–3 mol L–1 FeIII and 1.0 × 10–3 
mol L–1 TPTZ in acetate buffer solution, pH = 3.6); P: peristal-
tic pump (flow rate 2.0 mL min–1); V: injector valve (loop = 
500 µL); CP: confluence point; RC: reactor in coiled form 
(length: 300 cm, i.d. 0.8 mm); D: spectrophotometric detector 
(λ = 593 nm) equipped with flow cell (FC, 160 µL); H: com-
puter; W: waste. 
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dispersed sample zone reached the flow cell unit posi-
tioned in the optical path of the spectrophotometer (D) 
and the absorbance was continuously monitored at 593 
nm, yielding a transient signal. The peak height was 
employed as quantitative variable. 
Throughout the measurement, all the solutions 
(sample, standard, carrier and reagent solution) and the 
reactor in coiled form were thermostated in the water bath. 
 
RESULTS AND DISCUSSION 
The proposed method is based on a coupled redox-
complexation reaction. In the first (redox) step of the reac-
tion, NAC reduces FeIII to FeII. In the second step of the 
reaction, the reduced FeII is immediately converted to the 
highly stable Fe(TPTZ)22+ complex with well-defined 
absorption maximum at 593 nm. The kinetic properties of 
this coupled redox-complexation reaction were the subject 
of our previously reported batchwise kinetic method.24  
 
Optimization of Flow-injection and the Chemical 
Conditions 
Optimization of manifold parameters and experimental 
conditions were carried out by means of univariate me-
thod,25 in which a variable was modified while main-
taining the other variables at their constant values (se-
lected by random). Then by maintaining that variable at 
its optimum value, another was modified and this pro-
cedure was repeated for all variables.  
The optimal chemical conditions (pH value, con-
centrations of FeIII and TPTZ, temperature) for the 
coupled redox-complexation reaction, established in the 
previous kinetic study,24 have been confirmed for the 
flow-injection method (Table 1). 
The previous kinetic study24 has shown that ele-
vating the reaction temperature increases the rate of the 
considered reaction. However, due to the specificity of 
flow-injection system, the effect of temperature (pre-
sented with model equation: A = 0.017 t – 0.09) has a 
limitation. At temperatures higher than 30 °C the base-
line signal was not stable as a result of the air bubbles 
formed in the flow system. Therefore, a temperature of 
30 °C was selected as a compromise between the sensi-
tivity of the method and the reproducibility of the flow 
system. Performing the analysis at ambient laboratory 
conditions reduced the sensitivity of measurements but 
the reproducibility and repeatability were unaffected.  
 
Effect of Sample Injection Volumes 
In the flow systems, the sample volume injected con-
trols the amount of analyte inserted for reaction. In 
general, when sample volume is increased the analytical 
signal also increased. In the present case, sample loops 
with volumes of 100 µL to 1000 µL were tested. The 
absorbance signal importantly increased up to 500 µL, 
and volumes above 500 µL gave only a small increase 
in peak height. Additionally, for volumes higher than 
500 µL, the time spent to complete the transient signal 
was enlarged, which decreased the frequency of the 
system. Therefore, the sample volume of 500 µL was 
selected as a compromise with respect to the method 
sensitivity and the high sample throughput. 
 
Effect of Length of the Reactor in Coiled Form  
The length of the reactor in coiled form controls the 
reaction time between reagent and sample (analyte) 
inside the FIA system. When longer reactor was used, 
the contact time between NAC and reagent solution 
increased before the sample zone passed through the 
flow cell, concomitantly increasing the yield of the 
reaction. Also, in this situation, the mixing of the carrier 
(sample) and reagent streams is improved, which mini-
mizes the baseline noise. On the other hand, excessive 
increase of this variable can cause a decrease of analyti-
cal signal due to the increase of sample plug dispersion. 
The effect of reactor length was examined by varying 
the length from 100 cm to 525 cm (which is equivalent 
to volumes of 0.50 mL to 2.64 mL). The signal intensity 
increased with increasing the length of the reactor up to 
300 cm, and for longer reactors, signal intensity re-
mained almost identical. A reactor length of 300 cm was 
chosen as a compromise with respect to the sensitivity 
and the sample throughput. 
 
Effect of Flow Rate 
The effect of the flow rate of the carrier and reagent 
solution was investigated in the range of 0.5 mL min–1 
to 4.0 mL min–1. The results indicate that with increas-
ing flow rate, the sensitivity of the detection of NAC is 
lowered though the sampling frequency is higher. Con-
sidering the sensitivity and the sample throughput, the 
flow rate of 2.0 mL min–1 was chosen in the further 
experiments. Under optimized conditions sampling rate 
was 60 determinations per hour. The return time, de-
fined as the period between the appearance of the NAC 
signal maximum at concentrations ≤ 2.0 × 10–4 mol L–1 
and the return to the baseline, was less than 0.6 min. No 
baseline shift or absorbance drift was observed through-
out the 1 hour run. 
Under optimised conditions, the yield of coupled 
redox-complexation reaction was 60 %. This was ex-
Table 1. Optimization of chemical parameters for the coupled 
redox-complexation reaction 
Parameters Studied range 
Optimal 
conditions 
pH value 1.0 – 4.0 3.6 
molar ratio FeIII/NAC 0.5 – 10.0 5.0 
molar ratio TPTZ/NAC 0.5 – 10.0 5.0 
reaction temperature / °C  25 – 50 30 
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amined by using stop-flow experiment. The centre of 
the sample zone was stopped in the flow cell and kinetic 
of the reaction was continuously monitored for 1 hour 
afterwards (Figure 2). 
 
Effect of Internal Volume of Flow Cell 
The effect of internal volume of flow cell on signal inten-
sity was studied by changing the volume from 80 µL to 
500 µL. By increasing the volume of flow cell, the return 
time was increasing and the signal intensity was decreas-
ing. On the other hand, while performing the experiment 
at the optimal temperature (30 °C), baseline shifts were 
observed when the flow cell with smallest volume (80µL) 
was used. Therefore, the flow cell with internal volume of 
160 µL was chosen for further experiments. 
 
Analytical Characteristics 
Under the above-described optimum conditions, calibra-
tion curve was constructed covering the NAC concentra-
tion range from 6.0 ×10–6 mol L–1 to 2.0 ×10–4 mol L–1. 
Figure 3 shows a fiagram obtained by analysis of differ-
ent NAC standards. Linear regression analysis of peak 
height (y) versus NAC concentration (x) (n = 9) yielded 
the equation: y = 4.95 × 103 x – 0.028 (r2 = 0.9994).  
The limit of detection (LOD) and the limit of quantifica-
tion (LOQ) were calculated and found to be 2.0×10–6 
mol L–1 and 6.0 × 10–6 mol L–1, respectively. Spectral 
characteristics: apparent molar absorptivity and Sandell's 
sensitivity were calculated from the kinetic experimen-
tal results, and found to be 3.60 × 103 L mol–1 cm–1 and 
4.5 × 10–2 µg cm–2. At this point it should be stressed 
that the relative standard deviation of the slope of three 
calibration curves obtained on different working days 
with freshly prepared reagents, was smaller than 1.0 %.  
 
Repeatability 
The repeatability of the proposed method was assessed 
by carrying out ten consecutive injections of 1.0 × 10–4 
mol L–1 standard solution on a single occasion. The 
RSD of the measured peak heights was 0.29 %. This 
was considered to be satisfactory. 
 
Interferences Studies 
The effect of some possibly interfering cations and 
anions on the determination of NAC was investigated at 
a fixed NAC concentration (4.0 × 10–5 mol L–1 NAC) 
with different amounts of foreign ions in order to de-
termine the maximum tolerable foreign ion to NAC 
molar ratio. The influence of excipients that can com-
monly accompany NAC in pharmaceutical formulations 
was also studied. The tolerable concentration of K+, 
Na+, CO32– and HCO3– was 4.0 × 10–2 mol L–1 (ion to 
NAC molar ratio 1000 : 1) and the tolerable concentra-
tion of glucose, fructose, sucrose, boric acid and acetic 
acid was 2.0 × 10–3 mol L–1 (excipient to NAC molar 
ratio 500:1). The tolerable concentration of some other 
thiols (D-penicillamine, L-glutathione and L-cysteine) 
was 4.0 × 10–5 mol L–1 (thiol to NAC molar ratio 1:1).  
 
Figure 3. Fiagram chart and calibration curve (inlet) for spec-
trophotometric determination of NAC over the concentration 
range from 6.0 × 10–6 mol L–1 to 2.0 × 10–4 mol L–1. Fiagram 
includes recorded peaks for three samples: Fluimukan Gran-
ules (A); Fluimukan Akut Junior Syrup (B), and Fluimukan 
Akut Dispersible Tablets (C). 
 
Figure 2. The yied of coupled redox-complexation reaction 
examined by stop-flow experiment. Experimental conditions: 
c(NAC) = 1.0 × 10–4 mol L–1; reagent solution: c(FeIII) =  
1.0 × 10–3 mol L–1, c(TPTZ) = 1.0 × 10–3 mol L–1, pH = 3.6;  
t = 30 °C. 
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The tolerance limit is defined as the foreign ion or exci-
pient to analyte concentration ratio causing an error 
smaller than ± 5 % for determining the analyte of inter-
est. The pigment present in some samples did not inter-
fere in the absorbance measurements, which could be 
attributed to the low volume of the sample solution 
injected. It is worth mentioning that the absorbance 
measurement was performed in the visible region, away 
from the UV-absorption region of the possibly dissolved 
UV-absorbing excipient materials in the NAC-
containing pharmaceutical formulations. 
 
Accuracy 
The accuracy of measurements was checked by carrying 
out recovery studies. In this procedure, known amounts 
of the NAC standard solution, at levels of (50.0, 100.0, 
150.0, 200.0) µg mL–1, were added to preanalysed 
pharmaceutical formulations. Recoveries varied from  
98 % to 102 %, as shown in Table 2. These results 
prove good accuracy of the proposed method and the 
absence of interferences from common excipients, indi-
cating that the method is reliable for determination of 
NAC in pharmaceutical formulations.  
 
Application 
In order to evaluate the potential of the proposed me-
thod for the analysis of real samples, flow-injection 
spectrophotometric procedure was applied to different 
pharmaceutical formulations: granules (sample A), 
syrup (sample B), and dispersible tablets (sample C) for 
the determination of NAC. Recorded peaks referring to 
samples A, B, and C are shown in the Figure 3. As 
shown in Table 3, there were no significant differences 
between the results obtained by the method reported in 
the literature2 and those obtained by the method devel-
oped in this study (P > 0.1, student t-test). 
 
Conclusion 
In summary, a simple, rapid and sensitive flow-injection 
spectrophotometric method for the determination of 
NAC has been successfully developed and validated. By 
using TPTZ as the chromogenic agent the fast colour 
development reaction could be conducted easily at mild 
temperature conditions (30 °C). The proposed method 
has several advantages over previously reported flow-
injection spectrophotometric methods: higher sensitivi-
ty,17–20,22 use of commercially available equipment19–21 
and use of minimum number of reagents and reaction 
sequence.19 Additional advantages of the method are the 
wide linearity range and the very good reproducibility 
of calibration curves from day to day. The developed 
flow-injection spectrophotometric method was applied 
successfully for the determination of NAC in pharma-
ceutical formulations. Complex pre-treatment of the 
samples is not necessary: they are prepared simply by 
dissolving the pharmaceutical formulations in water. 
Usual excipients do not need to be removed since they 
do not interfere with the determination of NAC. These 
advantages encourage the application of the proposed 
method in the routine analysis of NAC in quality control 
laboratories. 
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Table 2. Evaluation of accuracy of flow-injection spectropho-
tometric method for the determination of NAC in pharmaceu-
tical formulations 
Sample Added γ /µg mL−1 
Found(a) 
γ /µg mL−1 Recovery / % 
Fluimukan 
Granules(b) 
0.0 102 ± 2 – 
50.0 151 ± 2 99 
100.0 201 ± 2 99 
150.0 254 ± 2 102 





0.0 101 ± 1 – 
50.0 151 ± 2 100 
100.0 199 ± 2 98 
150.0 252 ± 2 101 




0.0 100 ± 1 – 
50.0 151 ± 1 101 
100.0 199 ± 2 99 
150.0 248 ± 2 98 
200.0 303 ± 3 102 
(a) Average of three determinations ± SD. 
(b) Granules containing NAC 100 mg and excip. 
(c) Dispersible tablets containing NAC 600 mg and excip. 
(d) Syrup containing NAC 100 mg in 5 mL and excip. 
Table 3. Mass (average of three determinations ± SD) of  
NAC in pharmaceutical formulations determined by the 
method reported in the literature2 and the proposed flow-
injection spectrophotometric method 
Sample FIA method m / mg 
Reported method 2 
m / mg 
Fluimukan(a) 102 ± 2 103 ± 3 
Fluimukan 
Akut Junior(b) 100 ± 1 101 ± 1 
Fluimukan 
Akut(c) 603 ± 4 607 ± 7 
(a) Granules containing NAC 100 mg and excip. 
(b) Syrup containing NAC 100 mg in5 mL and excip. 
(c) Dispersible tablets containing NAC 600 mg and excip. 
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